council members can now access papers online! ** major advance *** – thank John Cosgrove for raising and driving this. topics for today that I spoke on – there is no point in repeating other peoples’ points, and we can only report what I said. have been elected to trustee board, thankyou. Will do my […]

Edinburgh 1969-78 hepatitis B  https://www.jstor.org/stable/4452769?seq=1 Prejudice against people with certain diseases, historically minimal risk to HPC re HIV Ebola impact on staff , deaths in healthcare staff due to Ebola , impact on communities, stigma, SARS impact , retrospective , analysis of outbreak in Toronto, impact on staff , post outbreak effects, Coronavirus Lancet stats, […]

potentially unnecessary vaginal examinations – study JAMA commentary 2013 systematic review Annals Internal Medicine 2014 PLCO study showing bimanual exams don’t help screen for ovarian cancer

lovely combination Blood pressure pills at night reproducibility crisis  review article  and old Cochrane review  new study – Hygia project  and trial registration (spot difference) old study and BP levels with diurnal meds – taking (similar bp results, didn’t address morbidity) MAPEC study HEAD LICE Nice guidance  resistance   wet combing   

a history of antidepressant withdrawal 1950s – class of drug called tricyclics started to be used for depression reports of withdrawal side effects in medical literature in 1960s and 70s suggesting slow withdrawals https://journals.sagepub.com/doi/10.1177/070674376601101S27 another class of drugs called MAOIs – again not commonly used nowadays for depression, available in 1950s onwards, lots of interactions […]

these are just notes, sorry! recall affects brand only, prescription only, zantac preparations (i.e. The four products affected are Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets and Zantac 300mg Tablets)  and not the over the counter version of  zantac or other generics of raniditine.  Issues with this contaminant since summer 2018 – issues with […]

NHSE document on prescription restrictions Headlice http://www.bad.org.uk/for-the-public/patient-information-leaflets/head-lice/?showmore=1&returnlink=http%3A%2F%2Fwww.bad.org.uk%2Ffor-the-public%2Fpatient-information-leaflets#.XZR045NKjfY https://www.bmj.com/content/331/7513/384 verucca /warts https://www.ncbi.nlm.nih.gov/pubmed/11686980 out of the chemicals dimeticone best https://www.ncbi.nlm.nih.gov/pubmed/31510998 NSAID gel https://www.cochrane.org/CD007402/SYMPT_topical-non-steroidal-anti-inflammatory-drugs-acute-musculoskeletal-pain-adults Cold sores A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis https://cks.nice.org.uk/herpes-simplex-oral    

the key trials are these two COMPASS and US retrospective study  pharmaceutical journal report medication safety report  NICE guidance growth in DOAC use  other issues https://www.amjmed.com/article/S0002-9343(15)00926-2/fulltext risk of bleeding scores after blood clots https://www.thrombosisresearch.com/article/S0049-3848(17)30047-6/fulltext https://link.springer.com/article/10.1007/s10840-014-9930-y This systematic review focused the high bleeding-risk category of commonly used risk scores in AF. Our main findings were as follows: (1) Overall […]

the key trials are these two COMPASS and US retrospective study  pharmaceutical journal report medication safety report  NICE guidance growth in DOAC use  other issues https://www.amjmed.com/article/S0002-9343(15)00926-2/fulltext risk of bleeding scores after blood clots https://www.thrombosisresearch.com/article/S0049-3848(17)30047-6/fulltext https://link.springer.com/article/10.1007/s10840-014-9930-y This systematic review focused the high bleeding-risk category of commonly used risk scores in AF. Our main findings were as follows: […]

https://www.longtermplan.nhs.uk/online-version/ https://www.england.nhs.uk/2019/09/nhs-to-review-making-statins-available-direct-from-pharmacists-as-part-of-long-term-plan-to-cut-heart-disease/ https://www.nice.org.uk/guidance/cg181/chapter/1-Recommendations#identifying-and-assessing-cardiovascular-disease-cvd-risk-2